Investor Brief on Centene

Large-cap Healthcare company Centene has logged a -1.5% change today on a trading volume of 3,195,709. The average volume for the stock is 3,499,141.

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Based in Saint Louis, Missouri, the company has 72,500 full time employees and a market cap of $43,624,669,184.

The company is now trading -22.35% away from its average analyst target price of $99.22 per share. The 18 analysts following the stock have set target prices ranging from $85 to $110, and on average give Centene a rating of buy.

Over the last year, CNC shares have gone down by -2.1%, which represents a difference of 10.5% when compared to the S&P 500. The stock's 52 week high is $98.53 per share and its 52 week low is $73.19.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.